Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the EuroHeart program, an observational and prospective multicenter initiative designed to improve quality of care for patients with common cardiovascular diseases such as Acute Coronary Syndrome ACS, heart failure, and atrial fibrillation. EuroHeart collects standardized and harmonized patient data to support continuous quality improvement by monitoring adherence to quality indicators defined by the European Society of Cardiology ESC. The program aims to understand how well proven treatments are applied in everyday clinical practice. The study involves continuous data collection from consecutive patients hospitalized or treated for these cardiovascular conditions. Participants enter a 12-month follow-up period during which clinical events and health status data are gathered. This registry specifically evaluates adherence to ESC quality indicators in Italian clinical practice, including measures such as time to reperfusion and prescription of recommended medications at discharge. Participants will be monitored through regular collection of clinical data over the 12 months following enrollment. Researchers will assess adherence to multiple ESC quality indicators related to treatment and management of STEMI and NSTEMI patients, including evaluations of left ventricular function, lipid levels, and use of dual antiplatelet therapy and other medications. The study also tracks cardiovascular and non-cardiovascular events during follow-up to support quality improvement efforts. Participation involves consent and data collection without experimental treatments.
Actively Recruiting
Researchers are evaluating the Tensi device, a medical transcutaneous-posterior tibial nerve stimulation TC-pTNS tool designed for managing overactive bladder OAB. This observational study aims to collect data from a large group of patients to assess the devices safety, effectiveness, and factors that might predict successful treatment in real-world clinical settings over one year. Participants will use the Tensi device as part of their management for idiopathic or neurological overactive bladder. The study involves monitoring patients over a total period of one year to observe outcomes related to symptom improvement and quality of life. No experimental drugs are involved since this is a post-market follow-up of an already released device. During the study, participants will provide feedback through patient-reported outcome measures and quality of life assessments at the start, 3 months, and 12 months. Researchers will track subjective improvements and safety throughout this period. The total participation time lasts one year, allowing for thorough observation of the devices use and effects in everyday clinical practice.